The assessment and management of gamma hydroxybutyrate use in general practice.

Aust J Gen Pract

BSc (Hons), MBChB, PhD, FRANZCP, FAChAM, Director, Turning Point, Eastern Health, Vic; Professor, Monash Addiction Research Centre and Eastern Health Clinical School, Monash University, Vic.

Published: September 2020

Background: Gamma hydroxybutyrate (GHB) is an illicit drug commonly used in music festival, party and 'chemsex' settings. Most people who use GHB do so occasionally, without dependent use or withdrawal symptoms. However, a minority of users experience harms including unconsciousness and respiratory collapse in overdose. Adverse interactions can also occur when GHB is used with other drugs (eg methamphetamine), necessitating assessment, management or onward referral by general practitioners.

Objective: This article describes the use of GHB, with a contemporary update on principles of assessment and management in general practice, brief intervention and harm-minimisation strategies, and indicators for referral to a specialist in dependent use.

Discussion: The assessment and management of individuals with GHB-related harms in general practice is supported by an awareness of the context of use, familiarity with targeted harm-minimisation advice and cognisance of markers of risk indicating onward referral to specialist addiction services when appropriate.

Download full-text PDF

Source
http://dx.doi.org/10.31128/AJGP-05-19-4953DOI Listing

Publication Analysis

Top Keywords

assessment management
16
general practice
12
gamma hydroxybutyrate
8
onward referral
8
assessment
4
management gamma
4
general
4
hydroxybutyrate general
4
practice background
4
background gamma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!